Shanghai, China

He Sun

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations in Cellular Therapy by He Sun

Introduction

He Sun, an innovative inventor based in Shanghai, China, has made significant contributions to the field of cellular therapy, particularly in treating solid tumors. With a remarkable portfolio of 10 patents, He Sun continues to push the boundaries of medical science through his groundbreaking work.

Latest Patents

One of He Sun's latest patents is focused on "Chimeric Antigen Receptor Cells for Treating Solid Tumor". This invention details compositions and methods aimed at employing CAR T therapy for effectively targeting solid tumors. The compositions include CAR proteins that can bind to specific siglec proteins or the peptide hormone kisspeptin, paving the way for new therapeutic avenues.

Another significant patent is related to "Modified Cell Expansion and Uses Thereof". This document outlines methods and compositions to enhance T cell responses as well as the expansion and maintenance of CAR cells, both in vivo and in vitro. It describes a method of improving T cell-based therapies by administering genetically modified T cells that incorporate two distinct chimeric antigen receptors (CARs), with each CAR designed to bind to different antigens. This dual-targeting strategy enhances the efficacy of cellular therapies by diversifying the immune response.

Career Highlights

He Sun has been associated with several organizations that have played a pivotal role in advancing cellular therapeutics. Notable companies include Innovative Cellular Therapeutics Holdings, Ltd. and Innovative Cellular Therapeutics Co., Ltd., where he contributed to various projects focused on innovative medical solutions.

Collaborations

During his career, He Sun has collaborated with distinguished colleagues, including Chengfei Pu and Zhiyuan Cao. Their collective expertise has resulted in advancements in the understanding and implementation of therapy involving modified cellular components.

Conclusion

He Sun is a prominent figure in the field of cellular therapy, particularly noted for his innovative inventions that target solid tumors. His ongoing research and patents reflect a dedication to enhancing treatment options for patients, making a lasting impact in medical science and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…